SCHEMBL28671642

SCHEMBL28671642

O=C(c1cc(C2CC2)nc2ccccc12)N1CCc2c(nc(N3CCOCC3)[nH]c2=O)C1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ TSHR P16473 3/20 0.45
▸ LMNA P02545 1/20 0.45
▸ MGLL Q99685 7/20 0.45
▸ POLB P06746 2/20 0.44
▸ SPR P35270 2/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HPGD P15428 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22410640 0.79 ALDH1A1 (0.50) ALDH1A1TSHRMGLLSPRADORA2A
SCHEMBL22410664 0.76 ALDH1A1 (0.47) ALDH1A1TSHRMGLLSPRADORA2A
SCHEMBL13209769 0.74 ALDH1A1 (0.67) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL6848735 0.73 TSHR (0.49) ALDH1A1TSHRMGLLSPRADORA2A
SCHEMBL22410903 0.71 ALDH1A1 (0.58) ALDH1A1TSHRLMNAPOLBSPR
SCHEMBL22410900 0.71 ADORA2A (0.59) ALDH1A1TSHRLMNAPOLBSPR
SCHEMBL22410619 0.70 ADORA2A (0.55) ALDH1A1MGLLSPRADORA2AADORA1
SCHEMBL22410656 0.70 KMT2A (0.50) ALDH1A1TSHRMGLLADORA2AADORA1
SCHEMBL22410613 0.69 ADORA2A (0.54) ALDH1A1MGLLSPRADORA2AADORA1
SCHEMBL6848943 0.69 TSHR (0.57) ALDH1A1TSHRPOLBSPRADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113710667-A Fused cyclic pyrimidinone derivatives for the treatment of HBV infection or HBV induced diseases 爱尔兰詹森科学公司 2021-11-26 — — CN claimed
CN-113710667-A Fused cyclic pyrimidinone derivatives for the treatment of HBV infection or HBV induced diseases 爱尔兰詹森科学公司 2021-11-26 — — CN disclosed
Send feedback